关注
Claudio Ferri
Claudio Ferri
在 cc.univaq.it 的电子邮件经过验证
标题
引用次数
年份
Are instructors correctly gauging ventilation competence acquired by course attendees?
F D'Agostino, FE Agrò, P Petrosino, C Ferri, G Ristagno
Resuscitation 200, 110240, 2024
2024
A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib
FM Mariani, A Alunno, F Carubbi, C Ferri
Reumatismo 76 (2), 2024
2024
Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk
P Palatini, A Virdis, S Masi, A Mengozzi, E Casiglia, V Tikhonoff, ...
Diagnostics 14 (13), 1314, 2024
2024
Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study
C Agabiti Rosei, A Paini, G Buso, A Maloberti, C Giannattasio, M Salvetti, ...
Metabolites 14 (6), 323, 2024
2024
May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey
R Del Pinto, C Agabiti Rosei, C Borghi, F Cipollini, S Cottone, ...
High Blood Pressure & Cardiovascular Prevention, 1-12, 2024
2024
AB0131 NOT ALL THAT HURTS IS FIBROMYALGIA: THE CHALLENGE OF DIFFERENTIAL DIAGNOSIS IN PATIENTS WITH A PRE-EXISTING DIAGNOSIS OR A CLINICAL SUSPICION FOR FIBROMYALGIA
A Alunno, P Altieri, A Cecchini, D Colella, M Litterio, A Paolucci, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 1299-1300, 2024
2024
POS0944 THE BURDEN OF METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PATIENTS WITH INFLAMMATORY ARTHRITIS AT ONSET AND THE ROLE OF COEXISTING PSORIASIS
A Alunno, G Baldini, F Bellisario, F Santilli, F Mai, FM Mariani, C Ferri, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 601-602, 2024
2024
AB0818 THE BURDEN AND CHARACTERISTICS OF NEUROLOGICAL SYMPTOMS IN PATIENTS WITH SJÖGREN DISEASE
A Alunno, FM Mariani, V Ritschl, CP Bouillot, A Vieira, T Stamm, C Ferri, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 1704-1705, 2024
2024
AB0196 AGE, BIOLOGIC SEX AND DISEASE TYPE INFLUENCE THE CARDIOVASCULAR BURDEN IN PATIENTS WITH INFLAMMATORY ARTHRITIS AT DISEASE ONSET
A Alunno, F Mai, G Baldini, F Bellisario, F Santilli, C Martini, V Moronti, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 1334-1334, 2024
2024
AB0138 UNRAVELLING THE NUANCES OF PAIN IN PRIMARY SJÖGREN’S SYNDROME
A Alunno, EDI Ruscio, S Cappannari, ME Carugno, E Matone, I Olivieri, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 1303-1304, 2024
2024
AB0814 SARCOPENIA AND SARCOPENIC OBESITY IN PRIMARY SJÖGREN’S SYNDROME
A Alunno, E Di Ruscio, S Cappannari, ME Carugno, E Matone, I Olivieri, ...
Annals of the Rheumatic Diseases 83 (Suppl 1), 1702-1702, 2024
2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry
L D’Erasmo, S Bini, M Casula, M Gazzotti, S Bertolini, S Calandra, ...
European Journal of Preventive Cardiology 31 (8), 1038-1047, 2024
22024
Prevalence, Clustering, and Current Management of Cardiovascular Risk Factors Upon First Referral to Hypertension Specialists: the APPROACH Study
R Del Pinto, C Agabiti Rosei, A Di Guardo, C Giannattasio, R Izzo, ...
High Blood Pressure & Cardiovascular Prevention, 1-11, 2024
2024
Physicians’ attitudes toward beta‐blockers for the treatment of hypertension in Italy, Poland, and Turkey
A Prejbisz, F Donnaloja, P Dobrowolski, A Tettamanti, A Januszewicz, ...
The Journal of Clinical Hypertension, 2024
2024
Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement
MP Schlaich, K Tsioufis, S Taddei, C Ferri, M Cooper, A Sindone, ...
Journal of Hypertension, 10.1097, 2024
2024
Prevalence, Awareness And Treatment Of Cardiovascular Risk Factors In Health Professionals In The Cardiovascular Field: The Protecto Esh-Siia Study
CA Rosei, R Del Pinto, C Giannattasio, M Bombelli, R Dell’Oro, ...
Journal of Hypertension 42 (Suppl 1), e88, 2024
2024
CARDIOMETABOLIC RISK FACTORS AND LIFESTYLE HABITS IN THE GENERAL POPULATION: RESULTS OF AN AWARENESS-RAISING EDUCATIONAL CAMPAIGN FOR HEALTH EMPOWERMENT
R Del Pinto, L Serio, E Campanozzi, E Marrone, V Moronti, J Santilli, ...
Journal of Hypertension 42 (Suppl 1), e167, 2024
2024
MAY MEASURE MONTH 2022 IN ITALY: RESULTS OF A NATIONWIDE SURVEY
R Del Pinto, CA Rosei, C Borghi, S Cottone, B Fabris, C Giannattasio, ...
Journal of Hypertension 42 (Suppl 1), e84, 2024
2024
The Interaction Between Glomerular Filtration Rate (Gfr)-Adjusted Uricemia And Insulin Resistance In Predicting Mortality: The Urrah Project
E Russo, F Viazzi, R Pontremoli, E Casiglia, G Desideri, L D’Elia, C Ferri, ...
Journal of Hypertension 42 (Suppl 1), e49-e50, 2024
2024
Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
A Boccatonda, L Del Cane, L Marola, D D’Ardes, G Lessiani, ...
Life 14 (4), 473, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20